| Literature DB >> 35637492 |
Vivian Nystrøm1,2, Hilde Lurås3,4, Tron Moger5, Ann-Chatrin Linqvist Leonardsen6,7.
Abstract
BACKGROUND: In Norway, municipal acute wards (MAWs) have been implemented in primary healthcare since 2012. The MAWs were intended to offer decentralised acute medical care 24/7 for patients who otherwise would be admitted to hospital. The aim of this study was to assess whether the MAW represents the alternative to hospitalisation as intended, through 1) describing the characteristics of patients intended as candidates for MAWs by primary care physicians, 2) exploring the need for extended diagnostics prior to admission in MAWs, and 3) exploring factors associated with patients being transferred from the MAWs to hospital.Entities:
Keywords: Health services research; Municipal acute wards; Pathways; Primary healthcare; Quality improvement; Register data; Regression analysis
Mesh:
Year: 2022 PMID: 35637492 PMCID: PMC9153207 DOI: 10.1186/s12913-022-08066-3
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.908
Characteristics of the five MAWs
| Number of beds | 11 | 8 | 10 | 4 | 7 |
| Travel distance to the hospital by car, minutes | 30 | 15 | 30 | 45 | 45 |
| Physician(s) present Weekdays (08–16) | yes | yes | yes | yes | yes |
| Physician(s) present Weekends (09–15) | yes | yes | yes | yes | no |
| Nurse(s) present | 24/7 | 24/7 | 24/7 | 24/7 | 24/7 |
| Travel distance to the casualty by car, minutes | 0 | 0 | 5 | 5 | 15a |
| Co-located with short-term care | yes | yes | yes | yes | yes |
| X-ray available | daytime | daytime | daytime | - | mobile X-ray to days per week |
| Laboratory haemoglobin, WBC differential, CRP, glucose and urine examinations available | daytime | daytime | daytime | daytime | daytime |
| Blood gas available | at causality | at causality | yes | no | at causality |
| ECG available | yes | yes | yes | yes | yes |
| Bladder scanning available | yes | yes | yes | yes | yes |
Abbreviations: MAW Municipality acute ward, Casualty after-hours emergency services provided by primary care physicians in dedicated locations, as consultation wards (no treatment), WBC differential white blood cell differential, CRP C-reactive protein, ECG Electrocardiogram, Blood gas a group of tests that are performed together to measure the pH and the amounts PaO2 and PaCO2 (arterial pressure of oxygen and carbon dioxide), bicarbonate (HCO3), lactate, Haemoglobin (Hb), electrolytes, and blood sugar present in a sample of blood, Bladder scanning ultrasonic reflections measures the amount of urine inside the bladder
a means that travel time by car to the casualty was 15 min in 2019 and 2020. Travel distance by car in 2014 – 2019 was 0 min
Fig. 1Patients admitted to the MAWs in the period 2014–2020. Regression 1 is presented in Table 3, while regression 2 is presented in Table 4
Univariate and multiple logistic regressions on patients needing extended diagnostics (total number of patients included in the regression analysis, n = 13,987)
| OR (95% Cl) | OR (95% Cl) | |
|---|---|---|
| Oral medication | 1.36 (1.23–1.51)* | 1.23 (1.09–1.40)* |
| Intravenous fluid therapy | 0.81 (0.72–0.90)* | 0.90 (0.73–0.95)* |
| Intravenous medication | 0.97 (0.86–1.08) | 1.02 (0.89–1.16) |
| Mobilization and pain relief | 1.32 (1.18–1.47)* | 1.05 (0.91–1.20) |
| Nebulizer therapy | 0.99 (0.85–1.16) | 0.73 (0.59–0.90)* |
| Oxygen therapy | 1.06 (0.90–1.24) | 1.08 (0.88–1.33) |
| Observation | 1.25 (1.10–1.41)* | 1.25 (1.08–1.45)* |
| General and unspecified | 0.63 (0.51–0.78)* | 0.61 (0.48–0.77)* |
| Digestive | 0.51 (0.41–0.63)* | 0.53 (0.42–0.67)* |
| Cardiovascular | 1.11 (0.87–1.42) | 0.98 (0.73–1.30) |
| Musculoskeletal | 1.11 (0.96–1.29) | 1.04 (0.87–1.24) |
| Neurological | 0.99 (0.76–1.28) | 0.86 (0.64–1.16) |
| Psychological | 0.47 (0.36–0.62)* | 0.44 (0.33–0.60)* |
| Skin | 0.79 (0.59–1.05) | 0.81 (0.59–1.11) |
| Endocrine/metabolic and nutritional | 0.42 (0.33–0.54)* | 0.45 (0.34–0.59)* |
| Urological | 0.79 (0.65–0.95)* | 0.67 (0.54–0.83)* |
| One Comorbidity | 1.21 (1.06–1.39)* | 1.25 (1.08–1.46)* |
| Two Comorbidities | 1.11 (0.78–1.60) | 1.24 (0.84–1.85) |
| | 0.95 (0.86–1.05) | 1.03 (0.92–1.16) |
| | 1.06 (1.02–1.09)* | 1.09 (1.05–1.13)* |
| | 1.03 (1.02–1.05)* | 1.01 (1.00–1.03) |
| MAW 2 | 2.28*(1.97–2.63) | 2.29*(1.92–2.72) |
| MAW 3 | 0.92 (0.79–1.05) | 1.00 (0.84–1.19) |
| MAW 4 | 1.11 (0.92–1.33) | 1.24 (1.00–1.54)* |
| MAW 5 | 0.76 (0.66–0.89)* | 0.94 (0.78–1.12) |
| Out-of-hour physician | 1.15 (1.03–1.27)* | 0.44 (0.38–0.51)* |
| Nursing home physician | 0.36 (0.13–0.99)* | 0.41 (0.09–1.79) |
| Evening | 0.36 (0.32–0.40)* | 0.25 (0.21–0.29)* |
| Night | 1.42 (1.26–1.60)* | 1.83 (1.59–2.10)* |
| Weekday | 0.94 (0.84–1.05) | 0.80 (0.69–0.93)* |
| Home healthcare services | 1.28 (1.14–1.44)* | 1.09 (0.94–1.26) |
| Hospital | 0.62 (0.52–0.74)* | 0.60 (0.49–0.73)* |
| Nursing home (short time care) | 1.06 (0.91–1.22) | 0.86 (0.72–1.03) |
| Nursing home (long time care) | 0.70 (0.33–1.53) | 1.28 (0.56–2.91) |
Regressions were logistic
OR Odds ratio, CI Confidence interval, MAW Municipal acute ward, ICPC-2 The International Classification of Primary Care-2, N Number in multiple analysis
*p-value significant at level 0.05
Univariate and multiple logistic regressions on patients transferred from MAW to hospital during the stay at MAW (total number patients included in the regression analysis, n = 14 202)
| Oral medication | 0.85 (0.78–0.93)* | 0.86 (0.77–0.95)* |
| Intravenous fluid therapy | 1.40 (1.28–1.53)* | 1.32 (1.19–1.47)* |
| Intravenous medication | 1.58 (1.44–1.73)* | 1.60 (1.45–1.81)* |
| Mobilization and pain relief | 0.75 (0.67–0.83)* | 0.95 (0.65–1.08) |
| Nebulizer therapy | 1.14 (1.00–1.30) | 0.78 (0.65–0.93)* |
| Oxygen therapy | 1.93 (1.71–2.18)* | 2.13 (1.81–2.51)* |
| Observation | 1.13 (1.02–1.27)* | 1.29 (1.13–1.48)* |
| Emptying regime/constipation | 0.84 (0.68–1.04) | 0.88 (0.69–1.13) |
| Bladder catheterization | 1.17 (0.92–1.50) | 1.11 (0.84–1.46) |
| Wound therapy | 0.73 (0.54–0.98)* | 0.82 (0.60–1.14) |
| Nutritional therapy | 1.27 (0.88–1.56) | 1.55 (1.14–2.12)* |
| General and unspecified | 1.16 (0.98–1.37) | 1.07 (0.89–1.29) |
| Digestive | 1.23 (1.06–1.43)* | 1.13 (0.94–1.35) |
| Cardiovascular | 1.26 (1.01–1.57)* | 1.31 (1.02–1.68)* |
| Musculoskeletal | 0.79 (0.68–0.91)* | 1.04 (0.87–1.24) |
| Neurological | 0.72 (0.55–0.94)* | 0.69 (0.52–0.92)* |
| Psychological | 0.71 (0.57–0.88)* | 0.67 (0.52–0.86)* |
| Skin | 0.96 (0.75–1.22) | 1.12 (0.86–1.47) |
| Endocrine/metabolic/nutritional | 0.81 (0.68–0.97)* | 0.75 (0.61–0.92) |
| Urological | 1.09 (0.93–1.29) | 1.18 (0.99–1.42) |
| One comorbidity | 0.97 (0.86–1.10) | 1.06 (0.93–1.22) |
| Two comorbidities | 0.96 (0.69–1.33) | 1.05 (0.73–1.51) |
| Male | 1.19 (1.09–1.30)* | 1.16 (1.05–1.27)* |
| | 0.97 (0.96–0.99)* | 1.05 (1.02–1.08)* |
| MAW 2 | 1.22 (1.04–1.41)* | 0.92 (0.77–1.10) |
| MAW 3 | 1.04 (0.92–1.18) | 0.83 (0.72–0.96)* |
| MAW 4 | 1.51 (1.30–1.76)* | 1.46 (1.22–1.74)* |
| MAW 5 | 1.68 (1.49–1.89)* | 1.04 (0.91–1.20) |
| Out-of-hour physician | 1.18 (1.08–1.29)* | 1.06 (0.93–1.21) |
| Nursing home physician | 0.96 (0.56–1.66) | 1.13 (0.51–2.50) |
| Evening | 1.06 (0.96–1.17) | 1.03 (0.91–1.17) |
| Night | 1.02 (0.90–1.16) | 0.85 (0.74–0.98)* |
| Weekday | 0.90 (0.81–0.99)* | 1.01 (0.89–1.14) |
| Home healthcare services | 0.99 (0.80–1.23) | 1.11 (0.87–1.43) |
| Extended diagnostic | 0.56 (0.47–0.66)* | 0.63 (0.52–0.76)* |
| Nursing homes | 1.09 (0.86–1.39) | 0.86 (0.64–1.15) |
Regressions were logistic
OR Odds ratio, CI Confidence interval, MAW Municipal acute ward, ICPC-2 The International Classification of Primary Care-2, N Number in multiple analysis
* p-value significant at level 0.05
Descriptive statistics for patients admitted to MAW in the period 2014 to 2020, N = 16 786
| Oral medication | 9682 (57.7) | 1146 (64.4) | 1306 (54.3) | |||
| Intravenous fluid therapy | 5482 (32.7) | 1275 (71.7) | 943 (39.2) | |||
| Intravenous medication | 4658 (27.7) | 481 (27.0) | 868 (36.2) | |||
| Mobilisation and pain relief | 3755 (22.4) | 482 (27.0) | 439 (18.2) | |||
| Observation | 2949 (17.6) | 367 (20.6) | 461 (18.7) | |||
| Oxygen therapy | 1763 (10.5) | 196 (11.1) | 404 (16.8) | |||
| Nebuliser therapy | 1904 (11.4) | 201 (11.3) | 301 (12.5) | |||
| Emptying regime/constipation | 790 (4.7) | 69 (3.9) | 98 (4.1) | |||
| Bladder catheterisation | 477 (2.8) | 48 (2.7) | 78 (3.2) | |||
| Wound therapy | 467 (2.8) | 50 (2.8) | 51 (2.1) | |||
| Blood transfusion | 433 (2.6) | 10 (0.6) | 11 (0.5) | |||
| Nutritional therapy | 355 (2.1) | 32 (1.8) | 58 (2.4) | |||
| Physical therapy | 199 (1.1) | 31 (1.7) | 14 (0.6) | |||
| Respiratory | 3814 (22.7) | 492 (33.4) | 595 (24.7) | |||
| Musculoskeletal | 2633 (15.7) | 375 (21.1) | 334 (13.9) | |||
| Digestive | 1619 (9.6) | 114 (6.4) | 300 (12.5) | |||
| Urological | 1504 (9.0) | 157 (8.8) | 253 (10.5) | |||
| Endocrine/ metabolic and nutritional | 1362 (8.1) | 78 (4.4) | 177 (7.4) | |||
| General and unspecified | 1318 (7.8) | 111 (6.3) | 233 (9.7) | |||
| Psychological | 978 (5.8) | 64 (3.6) | 113 (4.7) | |||
| Cardiovascular | 603 (3.6) | 85 (4.8) | 114 (4.7) | |||
| Blood, blood forming organs and immune mechanism | 604 (3.6) | 12 (6.7) | 31 (1.3) | |||
| Neurological | 585 (3.5) | 75 (4.2) | 69 (2.9) | |||
| Skin | 573 (3.4) | 60 (3.4) | 86 (3.6) | |||
| Pregnancy, childbearing, family planning | 163 (1.0) | 36 (2.0) | 17 (0.7) | |||
| Female genital | 41 (0.2) | 1 (< 0.0) | 11 (0.5) | |||
| Male genital | 38 (0.2) | 0 (0.0) | 8 (0.3) | |||
| Social Problems | 38 (0.2) | 3 (< 0.0) | 2 (0.1) | |||
| Ear | 33 (0.2) | 2 (< 0.0) | 1 (< 0.0) | |||
| Eye | 7 (< 0.1) | 0 (0.0) | 2 (0.1) | |||
| No comorbidities | 14,078 (83.9) | 1447 (81.3) | 2027 (84.2) | |||
| One comorbidity | 2212 (14.4) | 298 (16.8) | 338 (14.1) | |||
| Two comorbidies | 396 (1.8) | 34 (8.6) | 41 (1.7) | |||
| Female | 10,051 (59.9) | 1085 (61.0) | 1354 (56.3) | |||
| Male | 6693 (39.9) | 691 (38.8) | 1049 (43.6) | |||
| MAW 1 | 4630(27.6) | 463(26.0) | 548(22.8) | |||
| MAW 2 | 2111(12.6) | 428(24.0) | 296(12.3) | |||
| MAW 3 | 4217(25.1) | 392(22.0) | 517(21.5) | |||
| MAW 4 | 1823(10.9) | 181(10.2) | 308(12.8) | |||
| MAW 5 | 4005(23.9) | 315(17.7) | 737(30.6) | |||
| General Practitioner | 6900 (41.1) | 651 (36.6) | 916 (38.1) | |||
| Out-of-hour physician | 9337 (55.6) | 997 (56.0) | 1430 (59.4) | |||
| Nursing home physician | 117 (0.7) | 4 (0.0) | 15 (0.6) | |||
| Day | 5287 (31.5) | 739 (41.5) | 736 (30.6) | |||
| Evening | 8349 (49.7) | 454 (25.5) | 1222 (50.8) | |||
| Night | 3150 (18.8) | 586 (32.9) | 448 (18.6) | |||
| Weekend | 3911 (23.3) | 434 (24.4) | 601 (25.0) | |||
| Weekday | 12,875 (76.7) | 1345 (75.6) | 1805 (75.0) | |||
| Home | 13,490 (80.4) | 2025 (84.2) | ||||
| Home healthcare services | 654 (3.9) | 97 (4.0) | ||||
| Nursing homes | 514 (3.1) | 83 (4.4) | ||||
| Home | 6678 (39.8) | 693 (39.0) | ||||
| Home with home-nursing | 4345 (25.9) | 562 (31.6) | ||||
| Nursing home (short time care) | 2657 (15.8) | 287(16.1) | ||||
| Nursing home (long time care) | 96 (0.6) | 7 (0.4) | ||||
| Hospital | 2406 (14.3) | 160 (9.0) | ||||
|
|
|
| ||||
| Mean/Median | SD/IQR | Mean/Median | SD/IQR | Mean/ Median | SD/IQR | |
| 73.5/78 | 17.8/66–86 | 75/80 | 17.2/68–87 | 72.6/77 | 17.7/65–86 | |
| 3.4/3 | 3.3/1–5 | 3.8/3 | 3.3/2–5 | 2.9/1 | 2.7/1–3 | |
N Number, MAW Municipal acute Ward, ICPC-2 The International Classification of Primary Care-2; Age in years; Length of stay in days, SD Standard deviation, IQR Interquartile range